Results 131 to 140 of about 26,020 (296)

Participatory data collection

open access: yes, 2021
Participatory mapping (direct-to-digital participatory mapping, 3D-participatory mapping, participatory GIS), photovoice, transect walks, ranking exercises, focus group discussions, Venn diagrams, matrix scoring, ecograms, timelines, Q-methodology ...
de Vos, Alta   +2 more
core  

Locating the Risk: Using Participatory Mapping to Contextualize Perceived HIV Risk across Geography and Social Networks among Men Who Have Sex with Men in the Deep South. [PDF]

open access: yesJ Sex Res, 2022
Arnold T   +15 more
europepmc   +1 more source

Flood Hazard Mapping with Participatory GIS

open access: yesEnvironment and Urbanization ASIA, 2014
With cities representing concentrations of risk from many of the impacts of climate change, local communities are beginning to consider and implement actions to adapt to current or likely future impacts. Tools that can supplement existing community knowledage in assessing flood and other disaster risks have a valuable role to play, particularly in ...
openaire   +2 more sources

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

'Thinking-through-Complicity' with Te Iwi o Ngāti Hauiti: Towards a Critical Use of Participatory Video for Research

open access: yes, 2012
This thesis explores some of the seductions and dangers of participatory video for research (PVR) involving Indigenous Māori and Pākehā research partners.
Kindon, Sara Louise
core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Volunteered geographic information mobile application for participatory landslide inventory mapping

open access: yes, 2022
Participatory landslide inventory mapping using the Volunteered Geographic Information (VGI) mobile app is a promising method to produce a landslide inventory map.
Samodra, Guruh   +3 more
core  

MAP-it. The Art of Designing a Participatory Mapping Method

open access: yes, 2013
Operating within a complex design context, research group Social Spaces (MAD-Faculty, LUCA/KU Leuven) experiences that solving design problems is not straightforward and sometimes requires the design of new methods. Therefore, Social Spaces designed ‘MAP-it’: a participatory mapping method that enables designers to moderate design processes through ...
Schepers, Selina   +3 more
openaire   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy